{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-144929","form_type":"8-K","ticker":"ALGS","cik":"0001799448","company_name":"Aligos Therapeutics, Inc.","filed_at":"2024-05-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.170189+00:00","generated_at":"2026-06-01T09:48:57.356119+00:00","sec_items":["3.01","5.02"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Jack Nielsen resigns from board; Aligos out of compliance with Nasdaq Audit Committee rule","bullets":["Director Jack Nielsen resigned effective May 21, 2024 for personal reasons; no disagreement with company.","Audit Committee now has two members; Nasdaq requires three under Rule 5605(c)(2)(A).","Company notified Nasdaq of non-compliance on May 22, 2024 and plans to cure within 180-day period.","Aligos intends to appoint a qualified third director to Audit Committee within the cure period."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-144929","json":"https://secwatch.observer/filing/0001193125-24-144929.json","markdown":"https://secwatch.observer/filing/0001193125-24-144929.md","text":"https://secwatch.observer/filing/0001193125-24-144929.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799448/000119312524144929/0001193125-24-144929-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799448/000119312524144929/d840680d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T09:48:57.356119+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"39e93b0690","claim":"Jack Nielsen resigned as Director at Aligos Therapeutics, Inc..","evidence_excerpt":"The Company intends to appoint to the Audit Committee a third director who satisfies the criteria for service on the Audit Committee no later than 180 days after Mr. Nielsen’s resignation.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799448/000119312524144929/0001193125-24-144929-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}